Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth

As on 23 Oct 2026

logo

Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth

Equity

NAV

₹ 37.28

CAGR (3 Years)

19.06%

AUM (Cr)

₹ 1,077.52

Risk

Very High Risk

About Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes' objectives will be ach

Breakdown of this Fund

logo
Chemicals
1.47%
logo
Debt Others
5.66%
logo
Healthcare
41.94%
logo
Miscellaneous
1.51%
logo
Pharmaceuticals
100.06%

Market Capitalization

Get your FAQs right

What kind of returns does Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth provide?

plus

How much expense ratio is charged by Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?

plus

What is the AUM of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?

plus

What is the NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?

plus

What is the PE and PB ratio of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?

plus

What is the exit load of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?

plus

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions